Andrea and her innovation, Congenica, were supported by the NIA from 2015-2018.

Andrea is Head of Clinical Services, Congenica, a company founded on the world-leading genomic technology pioneered at the Wellcome Trust Sanger Institute and the Department of Health. Andrea has over 20 years’ experience in NHS genetic diagnostic laboratories and heads up a team of clinical scientists at Congenica who are responsible for the interpretation of cases for the UK 100,000 genome Project.

Congenica is a software for end-to-end genomic analysis.